Emerald Mutual Fund Advisers Trust Guardant Health, Inc. Transaction History
Emerald Mutual Fund Advisers Trust
- $1.23 Billion
- Q1 2025
A detailed history of Emerald Mutual Fund Advisers Trust transactions in Guardant Health, Inc. stock. As of the latest transaction made, Emerald Mutual Fund Advisers Trust holds 327,283 shares of GH stock, worth $15.5 Million. This represents 1.13% of its overall portfolio holdings.
Number of Shares
327,283Holding current value
$15.5 Million% of portfolio
1.13%Shares
1 transactions
Others Institutions Holding GH
# of Institutions
365Shares Held
118MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$569 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$531 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$303 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$257 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$247 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.83B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...